Global Respiratory Disposables Market Report 2020: Masks, Tubes, Inhalers, Others - Forecast to 2023, 2025 & 2030

News provided by

Jun 24, 2021, 18:00 ET

DUBLIN, June 24, 2021 /PRNewswire/ -- The "Respiratory Disposables Global Market Report 2020-30: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering.

The global respiratory disposables market is expected to grow from $1.5 billion in 2019 to $4.5 billion in 2020 at a compound annual growth rate (CAGR) of 199.5%.

The fact that COVID-19 is essentially a respiratory ailment has boosted the market growth. There is an increased demand for respiratory devices such ventilators, nebulizers, pulse oximeters and spirometers since oxygen therapy is a major intervention for patients with severe COVID-19 infection, and this factor is contributing to the market growth.

In order to compensate for lack of ventilators due to the huge demand and short supply, hospitals have started to convert anesthesia machines into breathing machines. The market is then expected to grow at a CAGR of 6.6% from 2021 and reach $3.2 billion in 2023.

High prevalence rate of respiratory diseases globally is driving the respiratory disposables market. Excessive smoking, exposure to toxic materials, adverse climate conditions and air pollution are some of the main causes which are leading to rise in respiratory diseases such as asthma, lung cancer, Chronic Obstructive Pulmonary Disease (COPD) and obstructive sleep apnea (OSA).

Respiratory disposables market is being restrained due to stringent regulatory policies. Regulatory agencies and governments across various countries are imposing stringent restrictions on product approval and launch, this is limiting the market growth. For instance, in 2005, FDA banned Amphastar Pharmaceutical's Primatene product, an albuterol CFC inhalers for asthma because of ozone-depleting chlorofluorocarbon (CFC) propellants have depleted the ozone layer.

In 2014, the FDA rejected Amphastar's first attempt to bring a reformulated version of Primatene mist to market. Again in 2016, the FDA rejected another application for Primatene Mist. In November 2018, FDA approved new formulation of Primatene Mist. Stringent regulations result in rise in development costs and potential sales loss due to delays in product launch, thus restraining the Respiratory disposables market.

Rapid advances in technology are driving innovation in respiratory disposable manufacturing. Areas of particular development are likely to be AIR gel technology, wearable technologies, and 3D printing technology. These technologies are being used in the manufacturing of respiratory disposables, resulting in higher productivity, lower costs and higher margins.

Companies in this market are increasingly focusing on AIR gel technology, in which gel is incorporated into the bag on the edges of the mask which helps to the protection of the skin and creates a bridge to minimize the irritation of the skin and for effective sealing.

For example, Vyair medical prepared Veraseal 2 disposable mask, used for acute care with AIR gel technology and advantage of vented and non-vented versions. Similarly, Sleepnet prepared Mojo ventilation masks with Airgel technology.

In the USA, occupational safety and health administration (OSHA) regulates all respiratory medical equipment, guidelines for which are specified in 29 CFR 1910. 134. Under OSHA, national institute for occupational safety and health/national personal protective technology laboratory (NIOSH/ NPPTL) provides market approval certificate and FDA approves the product for marketing.

Before market approval, all the medical devices should be analyzed appropriately by performing compatibility test within a hospital environment,. They are tested on Electrical bench and Non clinical performance testing is also required. Moreover, proper software verification, validation, and hazard analysis must be performed. Labels on the devices are required to include the purpose of the device.

In April 2018, Vyaire Medical acquired Acutronic Medical for an undisclosed amount. The acquisition is expected to enhance Vyaire's product portfolio, technological capabilities and expand their intellectual capital. Acutronic Medical develops and sells ventilation solutions for NICU's/PICU's, ICU's and Intensive Care Transportation. The company was founded in 1981 and is headquartered in Switzerland.

Major players in the market are Fisher & Paykel, Becton Dickinson Company, Ambu A/S, Smiths Medical, Armstrong Medical

Key Topics Covered:

1. Executive Summary

2. Respiratory Disposables Market Characteristics

3. Respiratory Disposables Market Size And Growth
3.1. Global Respiratory Disposables Historic Market, 2015-2019, $ Billion
3.2. Global Respiratory Disposables Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion

4. Respiratory Disposables Market Segmentation
4.1. Global Respiratory Disposables Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Masks
Tubes
Inhalers
Others

4.2. Global Respiratory Disposables Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Hospitals
Clinics
Ambulatory Care Centers
Others

4.3. Global Respiratory Disposables Market, Segmentation By Disease Indications, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Asthma
Chronic Obstructive Pulmonary Disorder
Tuberculosis
Lung Cancer
Other Chronic Respiratory Diseases

4.4. Global Respiratory Disposables Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Adult
Pediatric & Neonatal

5. Respiratory Disposables Market Regional And Country Analysis
5.1. Global Respiratory Disposables Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Respiratory Disposables Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Companies Mentioned